Evidence map›Paper›PMID 39770714›Full record

ArticleMicroorganisms2024

In Vitro Activity of Ampicillin Plus Ceftriaxone Against Non-

Javier García-González, María A Cañas, Guillermo Cuervo, Marta Hernández-Meneses, Miguel A Verdejo, Marta Bodro, Javier Díez de Los Ríos, Oriol Gasch, Alba Ribera, Carles Falces and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Javier García-GonzálezExperimental Endocarditis Laboratory, Hospital Clínic, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain.
María A CañasExperimental Endocarditis Laboratory, Hospital Clínic, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain.
Guillermo CuervoInfectious Diseases Service, Hospital Clínic, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-7075-943X
Marta Hernández-MenesesInfectious Diseases Service, Hospital Clínic, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain.
Miguel A VerdejoInfectious Diseases Service, Hospital Clínic, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-7870-0515
Marta BodroInfectious Diseases Service, Hospital Clínic, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-0520-8279
Javier Díez de Los RíosDepartment of Internal Medicine, Hospital de Vic, 08500 Vic, Spain.
Oriol GaschDepartment of Infectious Diseases, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, 08208 Sabadell, Spain.ORCID 0000-0001-8518-458X
Alba RiberaDepartment of Internal Medicine, Hospital de Barcelona, 08034 Barcelona, Spain.
Carles FalcesCardiology Service, Hospital Clínic, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-3483-3786
Andrés PerissinottiNuclear Medicine Service, Hospital Clínic, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0003-4190-2425
Bárbara VidalCardiology Service, Hospital Clínic, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain.
Eduard QuintanaCardiovascular Surgery Service, Hospital Clínic, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain.
Asunción MorenoInfectious Diseases Service, Hospital Clínic, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain.
Maria PiquetDepartment of Microbiology, Hospital Clínic, Biomedical Diagnostic Center (CDB) and ISGlobal, University of Barcelona, 08036 Barcelona, Spain.
Ignasi RocaDepartment of Microbiology, Hospital Clínic, Biomedical Diagnostic Center (CDB) and ISGlobal, University of Barcelona, 08036 Barcelona, Spain.
Mariana Fernández-PittolDepartment of Microbiology, Hospital Clínic, Biomedical Diagnostic Center (CDB) and ISGlobal, University of Barcelona, 08036 Barcelona, Spain.
Sol M San José-VillarDepartment of Microbiology, Hospital Clínic, Biomedical Diagnostic Center (CDB) and ISGlobal, University of Barcelona, 08036 Barcelona, Spain.
Cristina García-de-la-MàriaExperimental Endocarditis Laboratory, Hospital Clínic, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain.
José M MiróInfectious Diseases Service, Hospital Clínic, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-8057-7755
The Hospital Clínic Endocarditis Study Group

Funding

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain 80:20 research grant (2019-24).Instituto de Salud Carlos III PI17/01251 and PI20/00830Instituto de Salud Carlos III and the Ministerio de Economia y Competitividad Research grant (JR23/00035)MCIN/AEI/10.13039/501100011033 and co-financed by the European Development Regional Fund "A way to achieve Europe" I+D+i grant PID2021-127402OB-I00Pla estratègic de recerca i innovació en salut (PERIS) 2022-2024Sara Borrell personal research grant from the Instituto de Salud Carlos III CD21/00125, 2022-24Spanish Network for Research in Infectious Diseases REIPI RD06/0008
6 · The paper itself

Abstract

(1) Background: Alternative antibiotics are needed to treat infective endocarditis (IE) caused by non-

Indexed as

E. casseliflavusE. duransE. gallinarumE. hiraeenterococcal endocarditisE. raffinosusin vitro studysynergytime–kill curves

Identifiers

PMID39770714
PMCPMC11677854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.